Abstract Maternally expressed gene 3 (MEG3), a long non-coding RNA (lncRNA), has tumor-
suppressor properties and its expression is lost in several human tumors. However, its …

Background Long noncoding RNAs (lncRNAs) have been revealed to play essential role in
drug resistance of multiple cancers. LncRNA MEG3 was previously reported to be …

Non-small cell lung cancer (NSCLC) represents the most common and fatal type of primary
lung malignancies. NSCLC is often diagnosed at later stages and requires systemic …

Objectives Long non‐coding RNA s have identified to involve into the tumour cell
proliferation, apoptosis and metastasis. We previously found that up‐regulated Lnc RNA …

MEG3 as a tumor suppressor has been reported to be linked with pathogenesis of
malignancies including hepatocellular carcinoma (HCC). However, the mechanism of MEG3 …

Lung cancer‐associated mortality is the most common cause of cancer death worldwide.
Non‐coding RNA s (nc RNA s), with no protein‐coding ability, have multiple biological roles …

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death
worldwide. This study aims to understand the underlying mechanism of lncRNA, actin …

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide and the third
leading cause of cancer-related fatalities. Long non-coding RNAs (lncRNAs) are key …

Background MEG3, a lncRNA, has been verified in several tumors to function as tumor
suppressors including breast cancer development and progression, however, the …

Long non-coding RNAs (lncRNAs) play a pivotal role in tumorigenesis, exemplified by the
recent finding that lncRNA maternally expressed gene 3 (MEG3) inhibits tumor growth in a …